<\/div>\n

Veko Care, an Animal Health Pharmaceutical manufacturing company in India renewed Australian GMP approval<\/strong><\/p>\n

New Delhi (India), April 7: <\/strong>Veko Care<\/a> Pvt. Ltd, one of the fastest-growing Animal Health Pharmaceutical Manufacturing companies in India, has achieved a significant milestone by successfully renewing Australian GMP. With a world-class manufacturing facility, Veko Care has rapidly emerged as a leading player in the animal health space within a short span of time, exporting its products to more than 45 countries. <\/p>\n

Along with its overseas partners, Veko Care has secured over 200 Marketing Authorization \/ Product Registration across the globe, such as LATAM, AFRICA, CIS, and ASIA. Veko Care\u2019s manufacturing facility has been approved for GMP by prestigious organizations such as WHO GMP, APVMA -Australian, NDA-Uganda, ZAMRA – Zambia, and VMD – Kenya. The brand possesses one of the best manufacturing facilities for veterinary medicines in India and has cemented its position as a leader in the industry.<\/p>\n

Veko Care manufactures products for different animals, including Companion Animals (Cats & Dogs), Livestock & Cattle, Equine, Poultry, and speciality products for Aquaculture. The brand\u2019s greatest strength lies in manufacturing niche dosage forms. Veko Care\u2019s unwavering commitment to quality, innovation, and technology has set a new benchmark in the animal healthcare industry. Veko Care has a mission to be the most trusted name in the animal health sector.<\/p>\n

Commenting on the achievement, the Chairman of Veko Care, Mr.Manoj Agrawal, said, “We are <\/em>happy to announce that we have successfully renewed<\/em> Australian GMP. It is a testament to our commitment to quality and innovation in the animal health space. Our vision is to expand our horizons to 100 countries within the next two years<\/em>.”<\/p>\n

Since its inception, Veko Care has been expertly producing specialized Veterinary Pharmaceuticals in a myriad of dosage forms. The company started its operations in India in 2019 with a niche range of products for companion animals and equine. With a current national sales team of over 50 and an all-India presence, the brand plans to double its team size by the next financial year.  Veko Care has achieved a revenue CAGR of 128% in the last three years and has set a target of $5.5 million for the forthcoming financial year.<\/p>\n

For more information, please visit: https:\/\/vekocare.com\/<\/u><\/a><\/p>\n

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Veko Care, an Animal Health Pharmaceutical manufacturing company in India renewed Australian GMP approval New Delhi (India), April 7: Veko Care Pvt. Ltd, one of the fastest-growing Animal Health Pharmaceutical Manufacturing companies in India, has achieved a significant milestone by successfully renewing Australian GMP. With a world-class manufacturing facility, Veko Care has rapidly emerged as a leading player in the […]<\/p>\n","protected":false},"author":1,"featured_media":16563,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[627],"class_list":["post-16562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business"],"wpmagazine_modules_lite_featured_media_urls":{"thumbnail":["https:\/\/newstrackbhopal.com\/wp-content\/uploads\/2023\/04\/7-april-HE-150x150.jpg",150,150,true],"cvmm-medium":["https:\/\/newstrackbhopal.com\/wp-content\/uploads\/2023\/04\/7-april-HE-300x300.jpg",300,300,true],"cvmm-medium-plus":["https:\/\/newstrackbhopal.com\/wp-content\/uploads\/2023\/04\/7-april-HE-305x207.jpg",305,207,true],"cvmm-portrait":["https:\/\/newstrackbhopal.com\/wp-content\/uploads\/2023\/04\/7-april-HE-400x600.jpg",400,600,true],"cvmm-medium-square":["https:\/\/newstrackbhopal.com\/wp-content\/uploads\/2023\/04\/7-april-HE-600x600.jpg",600,600,true],"cvmm-large":["https:\/\/newstrackbhopal.com\/wp-content\/uploads\/2023\/04\/7-april-HE.jpg",900,600,false],"cvmm-small":["https:\/\/newstrackbhopal.com\/wp-content\/uploads\/2023\/04\/7-april-HE-130x95.jpg",130,95,true],"full":["https:\/\/newstrackbhopal.com\/wp-content\/uploads\/2023\/04\/7-april-HE.jpg",900,600,false]},"categories_names":{"2":{"name":"Business","link":"https:\/\/newstrackbhopal.com\/index.php\/category\/business\/"}},"tags_names":{"627":{"name":"business","link":"https:\/\/newstrackbhopal.com\/index.php\/tag\/business\/"}},"comments_number":"0","_links":{"self":[{"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/posts\/16562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/comments?post=16562"}],"version-history":[{"count":0,"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/posts\/16562\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/media\/16563"}],"wp:attachment":[{"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/media?parent=16562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/categories?post=16562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newstrackbhopal.com\/index.php\/wp-json\/wp\/v2\/tags?post=16562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}